| Pharmaceutical Information |
| Drug Name |
Estrone sulfate |
| Drug ID |
BADD_D00835 |
| Description |
Estrone sulfate (as estropipate) is a form of estrogen. It has several uses such as: alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics, treatment of vaginal atrophy, treatment of some types of breast cancer (particularly in men and postmenopausal women), treatment of prostate cancer and prevention of osteoporosis. |
| Indications and Usage |
Estropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB04574
|
| KEGG ID |
D00312
|
| MeSH ID |
C017296
|
| PubChem ID |
3001028
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
QTL48N278K
|
| Synonyms |
estrone sulfate | oestrone sulphate | estrone-3-sulfate | estrone sulfate, 16-(14)C-labeled | Evex | estrone sulfate, potassium salt | potassium estrone sulfate | estrone sulfate, sodium salt | sodium estrone sulfate | estrone sulfate, 14C-labeled | estrone sulfate, ammonium salt |
|
| Chemical Information |
| Molecular Formula |
C18H22O5S |
| CAS Registry Number |
481-97-0 |
| SMILES |
CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
